Similar articles

• Ptr1 and ZAR1 immune receptors confer overlapping and distinct bacterial pathogen effector specificities.

  Ahn YJ, Kim H, Choi S, Mazo-Molina C, Prokchorchik M, Zhang N, Kim B, Mang H, Koehler N, Kim J, Lee S, Yoon H, Choi D, Kim MS, Segonzac C, Martin GB, Schultink A, Sohn KH. Ahn YJ, et al. New Phytol. 2023 Sep;239(5):1935-1953. doi: 10.1111/nph.19073. Epub 2023 Jun 19. New Phytol. 2023. PMID: 37334551
• Bacterial Effectors Induce Oligomerization of Immune Receptor ZAR1 In Vivo.

  Hu M, Qi J, Bi G, Zhou JM. Hu M, et al. Mol Plant. 2020 May 4;13(5):793-801. doi: 10.1016/j.molp.2020.03.004. Epub 2020 Mar 16. Mol Plant. 2020. PMID: 32194243
• Structure-function analysis of ZAR1 immune receptor reveals key molecular interactions for activity.

  Baudin M, Schreiber KJ, Martin EC, Petrescu AJ, Lewis JD. Baudin M, et al. Plant J. 2020 Jan;101(2):352-370. doi: 10.1111/tpj.14547. Epub 2019 Nov 6. Plant J. 2020. PMID: 31557357
• Non-promoter hypermethylation of zygote arrest 1 (ZAR1) in human brain tumors.

  Watanabe T, Yachi K, Ohta T, Fukushima T, Yoshino A, Katayama Y, Shinojima Y, Terui T, Nagase H. Watanabe T, et al. Brain Tumor Pathol. 2011 Jul;28(3):199-202. doi: 10.1007/s10014-011-0019-3. Epub 2011 Feb 18. Brain Tumor Pathol. 2011. PMID: 21331615 Review.
• The ZAR1 protein in cancer; from epigenetic silencing to functional characterisation and epigenetic therapy of tumour suppressors.

  Deutschmeyer VE, Richter AM. Deutschmeyer VE, et al. Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188417. doi: 10.1016/j.bbcan.2020.188417. Epub 2020 Aug 21. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32828887 Review.